You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage 0 chronic lymphocytic leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 23, 2022

Chronic Lymphocytic Leukemia Stage A(0), Chronic Lymphocytic Leukemia Stage A(I), Chronic Lymphocytic Leukemia Stage A(II) Trial

Recruiting
  • Chronic Lymphocytic Leukemia Stage A(0)
  • +3 more
  • Low Dose Selenious Yeast Tablets
  • High Dose Selenious Yeast Tablets
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Nov 26, 2021

Monoclonal B-Cell Lymphocytosis, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in Scottsdale,

Terminated
Has Results
  • Monoclonal B-Cell Lymphocytosis
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 15, 2021

Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +71 more
  • Chicago, Illinois
  • +5 more
Oct 8, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Scottsdale, Arizona
  • +2 more
Jan 5, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • (no location specified)
Nov 22, 2023

Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

Active, not recruiting
  • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 20, 2023

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Loncastuximab Tesirine
    • (no location specified)
    Jul 24, 2023

    Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

    Active, not recruiting
    • Contiguous Stage II Small Lymphocytic Lymphoma
    • +11 more
    • MOR00208
    • +2 more
    • Columbus, Ohio
      The Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

    Completed
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Myeloma Coach or CLL Coach Mobile App
    • Springboard Beyond Cancer informational website
    • Durham, North Carolina
      Duke University
    Jun 23, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in

    Completed
    Has Results
    • B-cell Chronic Lymphocytic Leukemia
    • +4 more
    • alemtuzumab
    • +9 more
    • Rochester, Minnesota
      Mayo Clinic
    Jun 11, 2020

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
      • Manhasset, New York
        Feinstein Institute for Medical research
      Jul 6, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +5 more
      • (no location specified)
      Jul 21, 2023

      Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

      Recruiting
      • Relapsed or Refractory CD19+ B-cell Lymphoma
      • +2 more
      • TBI-2001
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jul 26, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 17, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Small Lymphocytic Lymphoma
      • (no location specified)
      Jul 19, 2023

      Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2022

      Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Stage I Chronic Lymphocytic Leukemia
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Mar 24, 2022

      Understanding Chronic Lymphocytic Leukemia

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Aug 1, 2022

        Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

        Recruiting
        • Hypogammaglobulinemia
        • +2 more
        • Columbus, Ohio
        • +1 more
        Jan 16, 2023